ADVB
Advanced Biomed Inc.
Nasdaq Services-Medical Laboratories
Emerging growth company

Key Financials

Net Income
$6.7M
↑ 304.9%
EPS (Diluted)
$5.33
↑ 3431.3%
Revenue
$127637
N/A
Operating Income
$-6233542
↓ 473.7%
Total Liabilities
$1.5M
↓ 51.4%
Shareholders' Equity
$12.3M
↑ 253.0%
Total Assets
$13.8M
↑ 111.1%
Operating Cash Flow
$-1946943.00
↑ 66.6%

Recent SEC Filings

Form Type Filed Date Link
10-K 10/13/2026 View on SEC
NT 10-K 9/28/2026 View on SEC
SCHEDULE 13G 9/22/2026 View on SEC
4 8/20/2026 View on SEC
SCHEDULE 13G/A 8/20/2026 View on SEC
SCHEDULE 13G 8/20/2026 View on SEC
RW 7/20/2026 View on SEC
8-K 7/17/2026 View on SEC
8-K 7/1/2026 View on SEC
8-K 6/30/2026 View on SEC

Company Information

Field Value
Ticker ADVB
Company Name Advanced Biomed Inc.
CIK 1941029
Sector Services-Medical Laboratories
Industry
Emerging growth company
Exchange Nasdaq
SIC Code 8071
SIC Description Services-Medical Laboratories
Entity Type operating
Fiscal Year End 0630
State of Incorporation NV
Phone 86-21-20510823